Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Significant Increase in Short Interest

Bluejay Diagnostics, Inc. (NASDAQ:BJDXGet Free Report) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 27,100 shares, a growth of 298.5% from the November 30th total of 6,800 shares. Currently, 4.9% of the company’s stock are sold short. Based on an average daily volume of 617,400 shares, the short-interest ratio is presently 0.0 days.

Institutional Trading of Bluejay Diagnostics

An institutional investor recently raised its position in Bluejay Diagnostics stock. Anson Funds Management LP raised its position in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDXFree Report) by 359.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 319,280 shares of the company’s stock after buying an additional 249,770 shares during the quarter. Anson Funds Management LP owned about 1.93% of Bluejay Diagnostics worth $41,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 18.47% of the company’s stock.

Bluejay Diagnostics Stock Down 3.5 %

Shares of NASDAQ BJDX traded down $0.13 during midday trading on Friday, reaching $3.62. 86,235 shares of the company’s stock traded hands, compared to its average volume of 171,963. The company has a market cap of $2.00 million, a price-to-earnings ratio of 0.00 and a beta of 0.70. Bluejay Diagnostics has a one year low of $3.03 and a one year high of $532.00. The stock’s 50 day simple moving average is $4.31 and its 200-day simple moving average is $24.13.

About Bluejay Diagnostics

(Get Free Report)

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.

Recommended Stories

Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.